Literature DB >> 25689902

Lipidomics applications for disease biomarker discovery in mammal models.

Ying-Yong Zhao1, Xian-Long Cheng, Rui-Chao Lin, Feng Wei.   

Abstract

Lipidomics is a lipid-targeted metabolomics approach focusing on comprehensive analysis of all lipids with which they interact in biology systems. Recent technological advances in MS and chromatography have greatly enhanced the developments and applications of metabolic profiling of diverse lipids in complex biological samples. Lipidomics will not only provide insights into the specific functions of lipid species in health and disease, but will also identify potential biomarkers for establishing preventive or therapeutic programs for human disease. In this review, recent applications of lipidomics to understand animal models of disease such as metabolic syndromes, neurodegenerative diseases, cancer and infectious diseases are considered. We also discuss the lipidomics for the future perspectives and their potential problems.

Entities:  

Keywords:  animal models; disease biomarkers; lipid biomarkers; lipid profiling; lipidome; lipidomics; liquid chromatography; mass spectrometry; metabolomics; system biology

Mesh:

Substances:

Year:  2015        PMID: 25689902     DOI: 10.2217/bmm.14.81

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  20 in total

Review 1.  Obesity and Diabetic Kidney Disease: Role of Oxidant Stress and Redox Balance.

Authors:  Kumar Sharma
Journal:  Antioxid Redox Signal       Date:  2016-05-04       Impact factor: 8.401

Review 2.  Review of Metabolomics-Based Biomarker Research for Parkinson's Disease.

Authors:  Xin Li; Xiaoying Fan; Hongtian Yang; Yufeng Liu
Journal:  Mol Neurobiol       Date:  2021-11-26       Impact factor: 5.590

3.  Integrated metabolomics coupled with pattern recognition and pathway analysis to reveal molecular mechanism of cadmium-induced diabetic nephropathy.

Authors:  Pin Gong; Mengrao Wang; Wenjuan Yang; Xiangna Chang; Lan Wang; Fuxin Chen
Journal:  Toxicol Res (Camb)       Date:  2021-07-06       Impact factor: 2.680

Review 4.  Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease.

Authors:  Judy Baek; Chenchen He; Farsad Afshinnia; George Michailidis; Subramaniam Pennathur
Journal:  Nat Rev Nephrol       Date:  2021-10-06       Impact factor: 42.439

Review 5.  Biomarkers: Delivering on the expectation of molecularly driven, quantitative health.

Authors:  Jennifer L Wilson; Russ B Altman
Journal:  Exp Biol Med (Maywood)       Date:  2017-12-03

6.  Lipid profiling suggests species specificity and minimal seasonal variation in Pacific Green and Hawksbill Turtle plasma.

Authors:  Chelsea E Clyde-Brockway; Christina R Ferreira; Elizabeth A Flaherty; Frank V Paladino
Journal:  PLoS One       Date:  2021-07-19       Impact factor: 3.240

7.  Global lipidomics identified plasma lipids as novel biomarkers for early detection of lung cancer.

Authors:  Zongtao Yu; Hankui Chen; Junmei Ai; Yong Zhu; Yan Li; Jeffrey A Borgia; Jin-Song Yang; Jicai Zhang; Bin Jiang; Wei Gu; Youping Deng
Journal:  Oncotarget       Date:  2017-11-11

8.  Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease.

Authors:  Shasha Li; Peng Xu; Ling Han; Wei Mao; Yiming Wang; Guoan Luo; Nizhi Yang
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

Review 9.  Biofluid lipidome: a source for potential diagnostic biomarkers.

Authors:  Arkasubhra Ghosh; Krishnatej Nishtala
Journal:  Clin Transl Med       Date:  2017-06-20

Review 10.  Omics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric Disorders.

Authors:  Sumit Sethi; Elisa Brietzke
Journal:  Int J Neuropsychopharmacol       Date:  2015-10-09       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.